Last 12 months
Inside the activity.
0 purchase rows · 9 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 08, 2022 Filed Jan 11, 2022 22:25 UTC |
Forbes AlexandriaDirector · President and CEO
|
Tax withholdingOrdinary Shares | 51,554 | $21.53 | $1,109,957.62 |
DisclosureSEC source: 0001179110-22-000414 · edgar.xml · nonDerivative · entry 2 Forbes Alexandria · CIK 0001678604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,109,227 F2 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 08, 2022 Filed Jan 11, 2022 22:25 UTC |
Forbes AlexandriaDirector · President and CEO
|
Exercise / conversionOrdinary Shares | 97,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-000414 · edgar.xml · nonDerivative · entry 1 Forbes Alexandria · CIK 0001678604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,160,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-half of restricted share units granted on January 8, 2020. F3 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 08, 2022 Filed Jan 11, 2022 22:25 UTC |
Giroux RichardCFO & COO
|
Exercise / conversionRestricted Share Units · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000413 · edgar.xml · derivative · entry 7 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Ordinary Shares · 75,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-half of restricted share units granted on January 8, 2020. F1 · derivative.expiration_date: Represents vesting of one-half of restricted share units granted on January 8, 2020. Read SEC document |
| January 08, 2022 Filed Jan 11, 2022 22:25 UTC |
Giroux RichardCFO & COO
|
Tax withholdingOrdinary Shares | 39,657 | $21.53 | $853,815.21 |
DisclosureSEC source: 0001179110-22-000413 · edgar.xml · nonDerivative · entry 2 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 848,661 F2 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 08, 2022 Filed Jan 11, 2022 22:25 UTC |
Giroux RichardCFO & COO
|
Exercise / conversionOrdinary Shares | 75,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-000413 · edgar.xml · nonDerivative · entry 1 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 888,318 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-half of restricted share units granted on January 8, 2020. F3 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 08, 2022 Filed Jan 11, 2022 22:25 UTC |
Naylor StuartChief Development Officer
|
Exercise / conversionRestricted Share Units · Derivative | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000412 · edgar.xml · derivative · entry 4 Naylor Stuart · CIK 0001742771 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Ordinary Shares · 80,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-half of restricted share units granted on January 8, 2020. F1 · derivative.expiration_date: Represents vesting of one-half of restricted share units granted on January 8, 2020. Read SEC document |
| January 08, 2022 Filed Jan 11, 2022 22:25 UTC |
Naylor StuartChief Development Officer
|
Tax withholdingOrdinary Shares | 37,600 | $21.53 | $809,528.00 |
DisclosureSEC source: 0001179110-22-000412 · edgar.xml · nonDerivative · entry 2 Naylor Stuart · CIK 0001742771 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 444,417 F2 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 08, 2022 Filed Jan 11, 2022 22:25 UTC |
Naylor StuartChief Development Officer
|
Exercise / conversionOrdinary Shares | 80,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-000412 · edgar.xml · nonDerivative · entry 1 Naylor Stuart · CIK 0001742771 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482,017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-half of restricted share units granted on January 8, 2020. F3 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 22:22 UTC |
Wollin Robert JGeneral Counsel and Secretary
|
GrantRestricted Share Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000407 · edgar.xml · derivative · entry 2 Wollin Robert J · CIK 0001815161 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F3 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F3 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 22:22 UTC |
Wollin Robert JGeneral Counsel and Secretary
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $21.53 | $0.00 |
DisclosureSEC source: 0001179110-22-000407 · edgar.xml · derivative · entry 1 Wollin Robert J · CIK 0001815161 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires 2032-01-06 F1 · derivative.exercise_date: The option vests as to one quarter of the total grant on January 7, 2023 and vests as to the remainder in 36 equal monthly installments thereafter. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 22:25 UTC |
Forbes AlexandriaDirector · President and CEO
|
GrantRestricted Share Units · Derivative | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000414 · edgar.xml · derivative · entry 4 Forbes Alexandria · CIK 0001678604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Ordinary Shares · 250,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F4 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F4 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 22:25 UTC |
Giroux RichardCFO & COO
|
GrantRestricted Share Units · Derivative | 210,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000413 · edgar.xml · derivative · entry 6 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,000 Underlying: Ordinary Shares · 210,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F4 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F4 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 22:25 UTC |
Naylor StuartChief Development Officer
|
GrantRestricted Share Units · Derivative | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000412 · edgar.xml · derivative · entry 3 Naylor Stuart · CIK 0001742771 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Ordinary Shares · 150,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F4 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F4 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 22:23 UTC |
Zeldin Robert KChief Medical Officer
|
GrantRestricted Share Units · Derivative | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000408 · edgar.xml · derivative · entry 2 Zeldin Robert K · CIK 0001745347 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Ordinary Shares · 70,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F3 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F3 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 22:23 UTC |
Zeldin Robert KChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $21.53 | $0.00 |
DisclosureSEC source: 0001179110-22-000408 · edgar.xml · derivative · entry 1 Zeldin Robert K · CIK 0001745347 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires 2032-01-06 F1 · derivative.exercise_date: The option vests as to one quarter of the total grant on January 7, 2023 and vests as to the remainder in 36 equal monthly installments thereafter. Read SEC document |
| December 23, 2021 Filed Jan 11, 2022 22:11 UTC |
Forbes AlexandriaDirector · President and CEO
|
GiftOrdinary Shares | 17,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000404 · edgar.xml · nonDerivative · entry 1 Forbes Alexandria · CIK 0001678604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,063,281 Read SEC document |
| December 14, 2021 Filed Jan 11, 2022 22:11 UTC |
Giroux RichardCFO & COO
|
GiftOrdinary Shares | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000405 · edgar.xml · nonDerivative · entry 3 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 813,318 Read SEC document |
| December 13, 2021 Filed Jan 11, 2022 22:11 UTC |
Giroux RichardCFO & COO
|
GiftOrdinary Shares | 3,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000405 · edgar.xml · nonDerivative · entry 2 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 814,718 Read SEC document |
| November 17, 2021 Filed Nov 18, 2021 22:43 UTC |
Forbes AlexandriaDirector · President and CEO
|
SaleOrdinary Shares | 15,000 | $19.86 | $297,900.00 |
DisclosureSEC source: 0001179110-21-010256 · edgar.xml · nonDerivative · entry 3 Forbes Alexandria · CIK 0001678604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,080,781 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F5 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $19.56 to $20.14, inclusive. Read SEC document |
| November 16, 2021 Filed Nov 18, 2021 22:43 UTC |
Forbes AlexandriaDirector · President and CEO
|
SaleOrdinary Shares | 3,200 | $20.53 | $65,696.00 |
DisclosureSEC source: 0001179110-21-010256 · edgar.xml · nonDerivative · entry 2 Forbes Alexandria · CIK 0001678604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,781 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F4 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.43 to $20.75, inclusive. Read SEC document |
| November 16, 2021 Filed Nov 18, 2021 22:43 UTC |
Forbes AlexandriaDirector · President and CEO
|
SaleOrdinary Shares | 11,800 | $19.82 | $233,876.00 |
DisclosureSEC source: 0001179110-21-010256 · edgar.xml · nonDerivative · entry 1 Forbes Alexandria · CIK 0001678604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,098,981 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $19.37 to $20.34, inclusive. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Jan 11, 2022 22:11 UTC |
Giroux RichardCFO & COO
|
GiftOrdinary Shares | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000405 · edgar.xml · nonDerivative · entry 1 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 818,218 Read SEC document |
| October 20, 2021 Filed Oct 21, 2021 21:28 UTC |
Giroux RichardCFO & COO
|
SaleOrdinary Shares | 6,956 | $21.28 | $148,023.68 |
DisclosureSEC source: 0001179110-21-009576 · edgar.xml · nonDerivative · entry 3 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 819,218 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2021. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F5 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.09 to $21.59, inclusive. Read SEC document |
| October 20, 2021 Filed Oct 21, 2021 21:28 UTC |
Giroux RichardCFO & COO
|
SaleOrdinary Shares | 13,744 | $20.93 | $287,661.92 |
DisclosureSEC source: 0001179110-21-009576 · edgar.xml · nonDerivative · entry 2 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 826,174 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2021. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F4 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.09 to $21.08, inclusive. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 21:28 UTC |
Giroux RichardCFO & COO
|
SaleOrdinary Shares | 1,300 | $20.07 | $26,091.00 |
DisclosureSEC source: 0001179110-21-009576 · edgar.xml · nonDerivative · entry 1 Giroux Richard · CIK 0001742734 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 839,918 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2021. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.02 to $20.22, inclusive. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 18, 2021 Filed Oct 20, 2021 21:16 UTC |
Forbes AlexandriaDirector · President and CEO
|
SaleOrdinary Shares | 6,179 | $17.92 | $110,727.68 |
DisclosureSEC source: 0001179110-21-009561 · edgar.xml · nonDerivative · entry 2 Forbes Alexandria · CIK 0001678604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,110,781 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F4 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.78 to $18.21, inclusive. Read SEC document |
| October 18, 2021 Filed Oct 20, 2021 21:16 UTC |
Forbes AlexandriaDirector · President and CEO
|
SaleOrdinary Shares | 23,821 | $17.21 | $409,959.41 |
DisclosureSEC source: 0001179110-21-009561 · edgar.xml · nonDerivative · entry 1 Forbes Alexandria · CIK 0001678604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,116,960 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $16.75 to $17.74, inclusive. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 18, 2021 Filed Oct 20, 2021 21:16 UTC |
Naylor StuartChief Development Officer
|
SaleOrdinary Shares | 12,000 | $17.95 | $215,400.00 |
DisclosureSEC source: 0001179110-21-009560 · edgar.xml · nonDerivative · entry 1 Naylor Stuart · CIK 0001742771 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 402,017 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.60 to $18.13, inclusive. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 20, 2021 Filed Jul 21, 2021 20:57 UTC |
Naylor StuartChief Development Officer
|
SaleOrdinary Shares | 9,390 | $15.06 | $141,413.40 |
DisclosureSEC source: 0001179110-21-007595 · edgar.xml · nonDerivative · entry 1 Naylor Stuart · CIK 0001742771 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,017 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.20, inclusive. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 21:16 UTC |
Naylor StuartChief Development Officer
|
SaleOrdinary Shares | 2,610 | $15.04 | $39,254.40 |
DisclosureSEC source: 0001179110-21-007499 · edgar.xml · nonDerivative · entry 1 Naylor Stuart · CIK 0001742771 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 423,407 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.24, inclusive. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:47 UTC |
LEVINE ARNOLD JDirector
|
GrantRestricted Share Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006659 · edgar.xml · derivative · entry 2 LEVINE ARNOLD J · CIK 0001124164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The restricted share units become settleable when the reporting person ceases to be a director. F3 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. F3 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:47 UTC |
LEVINE ARNOLD JDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $14.88 | $0.00 |
DisclosureSEC source: 0001179110-21-006659 · edgar.xml · derivative · entry 1 LEVINE ARNOLD J · CIK 0001124164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2031-06-09 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 21:23 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
|
GrantRestricted Share Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-005676 · form4.xml · derivative · entry 2 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share of the Issuer upon settlement. The restricted share units become settlable when Ellen Hukkelhoven ceases to be a director or the Issuer. Ms. Hukkelhoven a Managing Director of Perceptive Advisors, LLC (the "Advisor"). The restricted share units shall vest in a single annual installment upon the earlier of (1) June 10, 2022 or (2) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. F2 · derivative.exercise_date: Each restricted share unit converts into one ordinary share of the Issuer upon settlement. The restricted share units become settlable when Ellen Hukkelhoven ceases to be a director or the Issuer. Ms. Hukkelhoven a Managing Director of Perceptive Advisors, LLC (the "Advisor"). The restricted share units shall vest in a single annual installment upon the earlier of (1) June 10, 2022 or (2) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. F2 · derivative.expiration_date: Each restricted share unit converts into one ordinary share of the Issuer upon settlement. The restricted share units become settlable when Ellen Hukkelhoven ceases to be a director or the Issuer. Ms. Hukkelhoven a Managing Director of Perceptive Advisors, LLC (the "Advisor"). The restricted share units shall vest in a single annual installment upon the earlier of (1) June 10, 2022 or (2) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. F3 · ownership.nature: The Advisor may be deemed to have an indirect pecuniary interest in the securities reported herein because the Advisor has the right to receive the director compensation provided in respect of Ms. Hukkelhoven's board service through a partial management fee offset. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 21:23 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $14.88 | $0.00 |
DisclosureSEC source: 0001062993-21-005676 · form4.xml · derivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2031-06-09 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earliest of (1) June 10, 2022 or (2) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. F3 · ownership.nature: The Advisor may be deemed to have an indirect pecuniary interest in the securities reported herein because the Advisor has the right to receive the director compensation provided in respect of Ms. Hukkelhoven's board service through a partial management fee offset. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:50 UTC |
Mendoza NeilDirector
|
GrantRestricted Share Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006661 · edgar.xml · derivative · entry 2 Mendoza Neil · CIK 0001742502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The restricted share units become settleable when the reporting person ceases to be a director. F3 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. F3 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:50 UTC |
Mendoza NeilDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $14.88 | $0.00 |
DisclosureSEC source: 0001179110-21-006661 · edgar.xml · derivative · entry 1 Mendoza Neil · CIK 0001742502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2031-06-09 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:53 UTC |
SHENK THOMAS EDirector
|
GrantRestricted Share Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006665 · edgar.xml · derivative · entry 2 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The restricted share units become settleable when the reporting person ceases to be a director. F3 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. F3 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:53 UTC |
SHENK THOMAS EDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $14.88 | $0.00 |
DisclosureSEC source: 0001179110-21-006665 · edgar.xml · derivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2031-06-09 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:51 UTC |
Seligman NicoleDirector
|
GrantRestricted Share Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006663 · edgar.xml · derivative · entry 2 Seligman Nicole · CIK 0001683100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The restricted share units become settleable when the reporting person ceases to be a director. F3 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. F3 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:51 UTC |
Seligman NicoleDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $14.88 | $0.00 |
DisclosureSEC source: 0001179110-21-006663 · edgar.xml · derivative · entry 1 Seligman Nicole · CIK 0001683100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2031-06-09 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:48 UTC |
MARCUS JOEL SDirector
|
GrantRestricted Share Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006660 · edgar.xml · derivative · entry 2 MARCUS JOEL S · CIK 0001216955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The restricted share units become settleable when the reporting person ceases to be a director. F3 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. F3 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:48 UTC |
MARCUS JOEL SDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $14.88 | $0.00 |
DisclosureSEC source: 0001179110-21-006660 · edgar.xml · derivative · entry 1 MARCUS JOEL S · CIK 0001216955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2031-06-09 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:45 UTC |
Indyk MartinDirector
|
GrantRestricted Share Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006658 · edgar.xml · derivative · entry 2 Indyk Martin · CIK 0001766997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The restricted share units become settleable when the reporting person ceases to be a director. F3 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. F3 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:45 UTC |
Indyk MartinDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $14.88 | $0.00 |
DisclosureSEC source: 0001179110-21-006658 · edgar.xml · derivative · entry 1 Indyk Martin · CIK 0001766997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2031-06-09 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:43 UTC |
Hukkelhoven EllenDirector
|
GrantRestricted Share Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006654 · edgar.xml · derivative · entry 2 Hukkelhoven Ellen · CIK 0001743337 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The restricted share units become settleable when the reporting person ceases to be a director. F3 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. F3 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:43 UTC |
Hukkelhoven EllenDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $14.88 | $0.00 |
DisclosureSEC source: 0001179110-21-006654 · edgar.xml · derivative · entry 1 Hukkelhoven Ellen · CIK 0001743337 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2031-06-09 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:41 UTC |
Harris Keith R.Director
|
GrantRestricted Share Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006653 · edgar.xml · derivative · entry 2 Harris Keith R. · CIK 0001742703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Ordinary Shares · 20,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The restricted share units become settleable when the reporting person ceases to be a director. F3 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. F3 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:41 UTC |
Harris Keith R.Director
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $14.88 | $0.00 |
DisclosureSEC source: 0001179110-21-006653 · edgar.xml · derivative · entry 1 Harris Keith R. · CIK 0001742703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Ordinary Shares · 20,000 shares Expires 2031-06-09 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. Read SEC document |
| June 09, 2021 Filed Jun 9, 2021 21:38 UTC |
Forbes AlexandriaDirector · President and CEO
|
SaleOrdinary Shares | 4,153 | $15.04 | $62,461.12 |
DisclosureSEC source: 0001179110-21-006523 · edgar.xml · nonDerivative · entry 4 Forbes Alexandria · CIK 0001678604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,290,781 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F5 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.12, inclusive. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 21:38 UTC |
Forbes AlexandriaDirector · President and CEO
|
SaleOrdinary Shares | 20,180 | $15.02 | $303,103.60 |
DisclosureSEC source: 0001179110-21-006523 · edgar.xml · nonDerivative · entry 3 Forbes Alexandria · CIK 0001678604 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,294,934 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019. F3 · price: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F4 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.09, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.